Installation of an aryl boronic acid function into the external section of N-aryl-oxazolidinones: Synthesis and antimicrobial evaluation.

European Journal of Medicinal Chemistry
Cristina D CruzJesus E Perea-Buceta

Abstract

N-aryl-oxazolidinones is a prominent family of antimicrobials used for treating infections caused by clinically prevalent Gram-positive bacteria. Recently, boron-containing compounds have displayed intriguing potential in the antibiotic discovery setting. Herein, we report the unprecedented introduction of a boron-containing moiety such as an aryl boronic acid in the external region of the oxazolidinone structure via a chemoselective acyl coupling reaction. As a result, we accessed a series of analogues with a distal aryl boronic pharmacophore on the oxazolidinone scaffold. We identified that a peripheric linear conformation coupled with freedom of rotation and no further substitution on the external aryl boronic ring, an amido linkage with hydrogen bonding character, in addition to a para-relative disposition between boronic group and linker, are the optimal combination of structural features in this series for antimicrobial activity. In comparison to linezolid, the analogue comprising all those features, compound 20b, displayed levels of antimicrobial activity augmented by an eight-fold to a thirty-two-fold against a panel of Gram-positive strains, and a near one hundred-fold against Escherichia coli JW5503, a Gram-negative m...Continue Reading

References

Dec 3, 1998·Antimicrobial Agents and Chemotherapy·S M SwaneyD L Shinabarger
Dec 19, 2001·Lancet·D J Diekema, R N Jones
May 17, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L StevensBarry Hafkin
Nov 29, 2002·Current Drug Targets. Infectious Disorders·C W FordM R Barbachyn
Apr 8, 2003·Current Topics in Medicinal Chemistry·Douglas K Hutchinson
May 15, 2003·Angewandte Chemie·Michael R Barbachyn, Charles W Ford
Nov 19, 2003·Bioorganic & Medicinal Chemistry Letters·Steven D PagetMark J Macielag
Dec 4, 2004·Nature Medicine·Stuart B Levy, Bonnie Marshall
Jul 5, 2005·Expert Opinion on Investigational Drugs·D Shinabarger
Mar 11, 2006·Bioorganic & Medicinal Chemistry·Adam R RensloMikhail F Gordeev
Feb 12, 2008·Journal of Medicinal Chemistry·Rosemarie O'Shea, Heinz E Moser
Mar 5, 2008·Antimicrobial Agents and Chemotherapy·Laura LawrenceJoyce Sutcliffe
May 23, 2008·Journal of Medicinal Chemistry·Joseph A IppolitoErin M Duffy
Jul 30, 2008·Antimicrobial Agents and Chemotherapy·Eugene SkripkinFrançois Franceschi
Sep 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Daniel N WilsonPaola Fucini
Oct 25, 2008·Bioorganic & Medicinal Chemistry Letters·Jiacheng ZhouGraham Johnson
Aug 29, 2009·Science·Michael A Fischbach, Christopher T Walsh
Nov 17, 2009·Diagnostic Microbiology and Infectious Disease·Ronald N JonesJohn D Turnidge
Jan 28, 2010·Dalton Transactions : an International Journal of Inorganic Chemistry·Andrew L Korich, Peter M Iovine
Jun 17, 2010·Nature Reviews. Microbiology·Katie J SimmonsColin W G Fishwick
Nov 10, 2010·Annals of the New York Academy of Sciences·Michael N GwynnDavid J Payne
Feb 5, 2011·European Journal of Medicinal Chemistry·Weon Bin ImSung-Hwa Yoon
Jun 1, 2009·Nature Chemistry·Christopher W Murray, David C Rees
Dec 7, 2011·Antimicrobial Agents and Chemotherapy·Katherine S Long, Birte Vester
Dec 24, 2011·Annals of the New York Academy of Sciences·Karen Joy Shaw, Michael R Barbachyn
Apr 24, 2012·Chemical Reviews·Reem SmoumMorris Srebnik
May 1, 2013·Nature Reviews. Drug Discovery·Kim Lewis
Apr 4, 2014·Journal of Medicinal Chemistry·Mikhail F Gordeev, Zhengyu Y Yuan
Jul 6, 2014·Angewandte Chemie·Peter M WrightAndrew G Myers
Sep 23, 2014·Journal of Chemical Information and Modeling·Nadia K LittermanSean Ekins
Nov 26, 2015·Lancet·Ramanan LaxminarayanSally Davies
Mar 24, 2016·Angewandte Chemie·Mathieu F ChellatRainer Riedl
Apr 27, 2016·Current Opinion in Biotechnology·Andrew C PawlowskiGerard D Wright
Jul 16, 2016·Nature Reviews. Drug Discovery·Daniel A ErlansonHarren Jhoti
Jun 12, 2015·ACS Infectious Diseases·David M Shlaes
Sep 20, 2016·MedChemComm·Jesse A JonesKirk E Hevener
Oct 18, 2016·MedChemComm·Jed F Fisher, Shahriar Mobashery
Dec 3, 2016·Nature Reviews. Drug Discovery·Rita SantosJohn P Overington
Jan 15, 2017·Biochemical Pharmacology·Sheo B SinghLynn L Silver
May 11, 2017·Nature·Michelle F RichterPaul J Hergenrother

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.